- Home
- MRNA vs CIEN Comparison
MRNA vs CIEN Comparison
Compare MRNA & CIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | CIEN |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 60.7B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MRNA | CIEN |
|---|---|---|
| Price | $154.25 | $344.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 14 |
| Target Price | $34.27 | ★ $382.69 |
| AVG Volume (30 Days) | ★ 23.7M | 2.1M |
| Earning Date | 05-01-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.77 | ★ 46.55 |
| EPS | N/A | ★ 4.34 |
| Revenue | ★ $19,263,000,000.00 | $4,769,507,000.00 |
| Revenue This Year | $9.36 | $30.83 |
| Revenue Next Year | $15.43 | $19.87 |
| P/E Ratio | ★ N/A | $79.38 |
| Revenue Growth | 4.29 | ★ 18.79 |
| 52 Week Low | $22.28 | $133.88 |
| 52 Week High | $176.66 | $637.51 |
Technical Indicators
Market Signals| Indicator | MRNA | CIEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | 44.13 |
| Support Level | $46.85 | $317.45 |
| Resistance Level | $156.42 | $365.90 |
| Average True Range (ATR) | 9.54 | 20.30 |
| MACD | -1.67 | 1.05 |
| Stochastic Oscillator | 78.72 | 43.80 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CIEN Ciena Corporation
Ciena is a leader in high-speed optical connectivity, providing systems, components, and automation software for telecom providers and enterprises, such as data centers, to enable long-distance connectivity. The company operates through four primary business segments: networking platforms, platform software and services, Blue Planet automation software, and global services. While telecom carriers remain important customers, cloud providers and hyperscalers now drive a significant portion of the business. To meet the demands of AI data centers, customers are adopting Ciena's WaveLogic 6 platform, the first to support 1.6 terabits-per-second capacity.